Novartis
(NYSE:NVS)|
45.15 -1.77 (-3.77%) Dec 01 - Close |
|
|
|
After-Hours 45.60 +0.45 (1.00%) Mon, 1 Dec 2008 4:03 PM
- Compare NVS with:
- View: Line | Candlestick
Company Profile
Novartis
Lichtstrasse 35
Basel, 4056
Switzerland - Map
Phone: 41 61 3241111
Fax: 41 61 3248001
Website: www.novartis.com
CEO: Dr. Daniel Vasella, M.D.
Employees: 98,200
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Major
Pharmaceutical company
The Company provides healthcare solutions that address the evolving needs of patients & societies worldwide with a portfolio that includes innovative medicines, preventive vaccines & diagnostic tools, generic pharmaceuticals & consumer health produ
Recent news for NVS
-
Novartis malaria drug safe, effective-US FDA staff
Reuters - 6 hours ago
-
Overseas Clinical Trials Are Under the Microscope
The Wall Street Journal Online - 7 hours ago
-
[$$] Scrutiny Grows of Drug Trials Abroad
The Wall Street Journal Online - 16 hours ago
-
[$$] EU Blasts Drug Titans' Tactics
The Wall Street Journal Online - Nov 28 at 9:47 ET
-
[$$] EU Blasts Drug Titans' Tactics
The Wall Street Journal Online - Nov 28 at 6:58 ET
-
Will Patients Reject This Injection?
Motley Fool - Nov 28 at 10:55 ET
-
A Giving Strategy for Penny Pinchers
Motley Fool - Nov 28 at 10:19 ET
-
[$$] Biotech Mailbag: All About Alnylam
RealMoney by TheStreet.com - Nov 28 at 6:59 ET
-
Watson Gets Some Hand-Me-Downs
Motley Fool - Nov 26 at 1:11 ET
-
5-Star Stocks Poised to Pop: Novartis
Motley Fool - Nov 26 at 10:56 ET